Secondary Raynaud's Phenomenon
1 clinical trials · Condition
◉ Watch Secondary Raynaud's Phenomenon
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon (NCT02356809) | Artgen Biotech | 2015-03-01 |
Track Secondary Raynaud's Phenomenon automatically
Every clearance here is in the API, with alerts when new ones post.